VR Adviser as of Sept. 30, 2022
Portfolio Holdings for VR Adviser
VR Adviser holds 31 positions in its portfolio as reported in the September 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Tricida | 14.0 | $95M | 9.1M | 10.48 | |
Aclaris Therapeutics (ACRS) | 10.6 | $72M | 4.6M | 15.74 | |
Cogent Biosciences (COGT) | 8.9 | $60M | 4.0M | 14.92 | |
Relmada Therapeutics (RLMD) | 8.3 | $56M | 1.5M | 37.02 | |
Miragen Therapeutics (VRDN) | 6.5 | $44M | 2.1M | 20.51 | |
GH Research Ord Sh (GHRS) | 5.7 | $39M | 3.3M | 11.62 | |
Atyr Pharma (ATYR) | 4.7 | $32M | 11M | 3.00 | |
Pliant Therapeutics (PLRX) | 3.3 | $23M | 1.1M | 20.89 | |
Milestone Pharmaceuticals (MIST) | 3.3 | $22M | 2.4M | 9.19 | |
Terns Pharmaceuticals (TERN) | 3.2 | $22M | 3.7M | 5.89 | |
Marinus Pharmaceuticals (MRNS) | 3.1 | $21M | 3.2M | 6.65 | |
Gossamer Bio (GOSS) | 3.1 | $21M | 1.7M | 11.98 | |
Annexon (ANNX) | 2.9 | $20M | 3.2M | 6.18 | |
Instil Bio | 2.9 | $20M | 4.1M | 4.84 | |
Akouos | 2.8 | $19M | 2.8M | 6.76 | |
Dice Therapeutics | 2.3 | $16M | 765k | 20.28 | |
Aerovate Therapeutics (AVTE) | 2.0 | $14M | 834k | 16.58 | |
LianBio Spons Adr (LIANY) | 1.6 | $11M | 5.4M | 2.00 | |
Fulcrum Therapeutics (FULC) | 1.4 | $9.7M | 1.2M | 8.09 | |
Inozyme Pharma (INZY) | 1.1 | $7.3M | 2.7M | 2.68 | |
Ventyx Biosciences (VTYX) | 1.1 | $7.3M | 208k | 34.91 | |
Prometheus Biosciences | 1.1 | $7.2M | 122k | 59.01 | |
Savara (SVRA) | 1.0 | $7.1M | 4.6M | 1.55 | |
Provention Bio | 0.7 | $5.0M | 1.1M | 4.50 | |
Altimmune (ALT) | 0.7 | $4.7M | 369k | 12.77 | |
Trevi Therapeutics (TRVI) | 0.7 | $4.7M | 3.1M | 1.54 | |
Lyra Therapeutics (LYRA) | 0.7 | $4.6M | 924k | 5.01 | |
Immunocore Holdings Ads (IMCR) | 0.7 | $4.4M | 95k | 46.94 | |
Rallybio Corp (RLYB) | 0.6 | $3.9M | 269k | 14.47 | |
Affimed Therapeutics B V | 0.4 | $2.9M | 1.4M | 2.06 | |
Celldex Therapeutics (CLDX) | 0.3 | $2.1M | 75k | 28.11 |